frost-sullivan-south-korea-is-estimated-to-earn-revenues-of-usd89

F&S: S. Korea will be biosimilars leader by 2020

  • Korea
  • |
  • Analysis
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

‎Singapore: Since South Korea introduced a regulatory pathway for manufacturing biologics in 2009, the government has raised its stakes in the biosimilars market.... Read more

pharmascience-korea-a-korean-canadian-generics-joint-venture-is-born

Canadian generic maker enters Korea with JV

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Montreal-based generic drug developer and marketer Pharmascience is venturing into Korea by forming a joint venture (JV) with Seoul-based Korea Kolmar... Read more

bioscience-industry-trends-2013

What bioscience trends do the industry leaders predict for...

  • China
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 1 Comment

The bioscience industry is about to step into 2013 and the year is predicted to unfold with new opportunities and trends that were so far just talk in the laboratories.... Read more

stem-cell-therapy-market-in-apac-to-be-worth-usd972-million-in-2018

APAC stem cell therapy market to reach $972mn in 2018

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A new study by Reports and Reports predicted that the stem cell therapy market in Asia Pacific (APAC) will grow in value from $545 million in 2012 to... Read more

license-agreement-yuhan-to-use-cevec-cap-t-technology

CEVEC signs deal with Yuhan in South Korea

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: CEVEC Pharmaceuticals, the developer of a novel human expression system derived from amniocytes, and Yuhan Corporation, a leading manufacturer of pharmaceutical... Read more

astrazeneca-legochem-collaborate-to-develop-antibiotic-resistant-bacterial-infections-drug

AstraZeneca, LegoChem drug to curb superbugs

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: AstraZeneca has formed collaboration with Korea's LegoChem Biosciences to develop a novel antibiotic to treat drug-resistant bacterial infections. The... Read more

cevec-pharmaceuticals-yuhan-sign-cap-technology-license-agreement

CEVEC, Yuhan sign deal for immortalized cell lines

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: CEVEC Pharmaceuticals, the developer of a novel human expression system derived from amniocytes, and Yuhan, a leading manufacturer of pharmaceutical... Read more

Biotech-310x175_copy

ASKLEP joins Medidata partner program

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: ASKLEP, a leading Tokyo-based provider of clinical research services, has joined the Medidata Solutions Partner Program as part of its strategy to expand... Read more

quintiles-signs-bioanalytical-deal-with-korean-cro

Quintiles signs bioanalytical deal with Korean CRO

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: To enhance its bioanalytical service offerings in Asia, Quintiles has signed an exclusive partnership with BioCore, a leading Seoul-based bioanalytical... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X